Sector
PharmaceuticalsOpen
₹124.95Prev. Close
₹123.75Turnover(Lac.)
₹0.43Day's High
₹129.9Day's Low
₹124.9552 Week's High
₹15452 Week's Low
₹55.1Book Value
₹91.06Face Value
₹10Mkt Cap (₹ Cr.)
19.49P/E
47.6EPS
2.6Divi. Yield
029 Jul 2024
12:00 AM
AGM
Announcement Date: 29 Jul, 2024
29 Jul 2024
12:00 AM
BookCloser
2 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 1.5 | 1.5 | 1.5 | 1.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 11.3 | 10.1 | 10.05 | 9.49 |
Net Worth | 12.8 | 11.6 | 11.55 | 10.99 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.17 | -0.12 | -0.19 | -0.15 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.36 | 0.31 | 0.49 | 0.76 |
Depreciation | -0.01 | -0.02 | -0.02 | 0 |
Tax paid | 0.19 | -0.06 | -0.07 | -0.66 |
Working capital | -4.71 | 2.21 | 0.27 | -0.14 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | 21.5 | -30.47 | 41.56 | 24.33 |
EBIT growth | 17.45 | -37.12 | -35.26 | -85.69 |
Net profit growth | 123.91 | -39.76 | 312.56 | -97.85 |
| Particulars (Rupees in Crores.) | Mar-2016 |
|---|---|
Gross Sales | 0 |
Excise Duty | 0 |
Net Sales | 0 |
Other Operating Income | 0.49 |
Other Income | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & CFO
Ashok Somani
Independent Director
Toby Antony
Non Executive Director
Shanta Somani
Independent Director
Mathura Prasad Sharma
Director & Chief Executive Off
Bhavin Sheth
Independent Director
Nandkumar Pareek
Company Sec. & Compli. Officer
Unnatti Jain
Managing Director & CEO
Ruchit Mehta
Additional Director & CFO
Utsav Trivedi
Additional Director
Sarvagya Goel
Additional Director
Shilpy Chopra
Company Sec. & Compli. Officer
Bhawna Rajput
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Chemo Pharma Laboratories Ltd
Summary
Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.
Read More
What is the Chemo Pharma Laboratories Ltd share price today?
The Chemo Pharma Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹129.9 today.
What is the Market Cap of Chemo Pharma Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chemo Pharma Laboratories Ltd is ₹19.49 Cr. as of 09 May ‘25
What is the PE and PB ratio of Chemo Pharma Laboratories Ltd?
The PE and PB ratios of Chemo Pharma Laboratories Ltd is 47.6 and 1.36 as of 09 May ‘25
What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Chemo Pharma Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Chemo Pharma Laboratories Ltd is ₹55.1 and ₹154 as of 09 May ‘25
What is the CAGR of Chemo Pharma Laboratories Ltd?
Chemo Pharma Laboratories Ltd's CAGR for 5 Years at 76.87%, 3 Years at 48.81%, 1 Year at 53.38%, 6 Month at 43.90%, 3 Month at 79.22% and 1 Month at -0.60%.
What is the shareholding pattern of Chemo Pharma Laboratories Ltd?
The shareholding pattern of Chemo Pharma Laboratories Ltd is as follows:
Promoters - 27.89 %
Institutions - 0.37 %
Public - 71.75 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
